CORCEPT THERAPEUTICS INC Share-based Payment Arrangement, Expense
CORCEPT THERAPEUTICS INC (CORT) reported Share-based Payment Arrangement, Expense of $6.51 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2018-11-02
- CORCEPT THERAPEUTICS INC share-based payment arrangement, expense for the quarter ending 2018-09-30 was $6.51M, a 79.69% increase year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, expense for the quarter ending 2018-06-30 was $6.02M, a 87.74% increase year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, expense for the quarter ending 2018-03-31 was $4.95M, a 83.41% increase year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, expense for the quarter ending 2017-12-31 was $3.83M, a 95.81% increase year-over-year.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, expense for fiscal 2017 was $13.36M, a 89.30% increase from fiscal 2016.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, expense for fiscal 2016 was $7.06M, a 17.38% increase from fiscal 2015.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, expense for fiscal 2015 was $6.01M, a 15.61% increase from fiscal 2014.
- CORCEPT THERAPEUTICS INC share-based payment arrangement, expense for fiscal 2014 was $5.20M, a 0.10% increase from fiscal 2013.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 158 month | Share-based Payment Arrangement, Expense 161 month | Share-based Payment Arrangement, Expense 164 month |
|---|---|---|---|---|---|---|---|
| 2018-09-30 | $6.51M 10-Q · filed 2018-11-02 | $12.53M derived: sum of 2 quarters · filed 2018-11-02 | $17.48M 10-Q · filed 2018-11-02 | $21.31M derived: sum of 4 quarters · filed 2018-11-02 | |||
| 2018-06-30 | $6.02M 10-Q · filed 2018-08-09 | $10.97M 10-Q · filed 2018-08-09 | $14.80M derived: sum of 3 quarters · filed 2018-08-09 | $18.43M derived: sum of 4 quarters · filed 2018-11-02 | |||
| 2018-03-31 | $4.95M 10-Q · filed 2018-05-09 | $8.79M derived: sum of 2 quarters · filed 2018-05-09 | $12.41M derived: sum of 3 quarters · filed 2018-11-02 | $15.61M derived: sum of 4 quarters · filed 2018-11-02 | |||
| 2017-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $7.46M derived: sum of 2 quarters · filed 2018-11-02 | $10.66M derived: sum of 3 quarters · filed 2018-11-02 | $13.36M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | $3.62M 10-Q · filed 2018-11-02 | $6.83M derived: sum of 2 quarters · filed 2018-11-02 | $9.53M 10-Q · filed 2018-11-02 | $11.49M derived: sum of 4 quarters · filed 2018-11-02 | |||
| 2017-06-30 | $3.21M 10-Q · filed 2018-08-09 | $5.91M 10-Q · filed 2018-08-09 | $7.86M derived: sum of 3 quarters · filed 2018-08-09 | $9.69M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $2.70M 10-Q · filed 2018-05-09 | $4.66M derived: sum of 2 quarters · filed 2018-05-09 | $6.49M derived: sum of 3 quarters · filed 2018-05-09 | $8.14M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $3.79M derived: sum of 2 quarters · filed 2018-02-28 | $5.44M derived: sum of 3 quarters · filed 2018-02-28 | $7.06M 10-K · filed 2018-02-28 | |||
| 2016-09-30 | $1.83M 10-Q · filed 2017-11-03 | $3.49M derived: sum of 2 quarters · filed 2017-11-03 | $5.10M 10-Q · filed 2017-11-03 | $6.59M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | $1.66M 10-Q · filed 2017-08-02 | $3.27M 10-Q · filed 2017-08-02 | $4.76M derived: sum of 3 quarters · filed 2018-02-28 | $6.30M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | $1.61M 10-Q · filed 2017-05-02 | $3.11M derived: sum of 2 quarters · filed 2018-02-28 | $4.65M derived: sum of 3 quarters · filed 2018-02-28 | $6.22M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $3.04M derived: sum of 2 quarters · filed 2018-02-28 | $4.60M derived: sum of 3 quarters · filed 2018-02-28 | $6.01M 10-K · filed 2018-02-28 | |||
| 2015-09-30 | $1.54M 10-Q · filed 2016-11-02 | $3.11M derived: sum of 2 quarters · filed 2016-11-02 | $4.52M 10-Q · filed 2016-11-02 | $5.91M derived: sum of 4 quarters · filed 2017-03-06 | |||
| 2015-06-30 | $1.57M 10-Q · filed 2016-08-03 | $2.98M 10-Q · filed 2016-08-03 | $4.36M derived: sum of 3 quarters · filed 2017-03-06 | $5.57M derived: sum of 4 quarters · filed 2017-03-06 | |||
| 2015-03-31 | $1.41M 10-Q · filed 2016-05-04 | $2.80M derived: sum of 2 quarters · filed 2017-03-06 | $4.01M derived: sum of 3 quarters · filed 2017-03-06 | $5.23M derived: sum of 4 quarters · filed 2017-03-06 | |||
| 2014-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $2.60M derived: sum of 2 quarters · filed 2017-03-06 | $3.82M derived: sum of 3 quarters · filed 2017-03-06 | $5.20M 10-K · filed 2017-03-06 | |||
| 2014-09-30 | $1.21M 10-Q · filed 2015-11-06 | $2.44M derived: sum of 2 quarters · filed 2015-11-06 | $3.81M 10-Q · filed 2015-11-06 | $5.13M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-06-30 | $1.23M 10-Q · filed 2015-08-07 | $2.60M 10-Q · filed 2015-08-07 | $3.92M derived: sum of 3 quarters · filed 2016-03-10 | $5.23M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-03-31 | $1.38M 10-Q · filed 2015-05-08 | $2.69M derived: sum of 2 quarters · filed 2016-03-10 | $4.00M derived: sum of 3 quarters · filed 2016-03-10 | $5.26M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2013-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $2.62M derived: sum of 2 quarters · filed 2016-03-10 | $3.89M derived: sum of 3 quarters · filed 2016-03-10 | $5.20M 10-K · filed 2016-03-10 | |||
| 2013-09-30 | $1.31M 10-Q · filed 2014-11-07 | $2.57M derived: sum of 2 quarters · filed 2014-11-07 | $3.88M 10-Q · filed 2014-11-07 | $4.93M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2013-06-30 | $1.26M 10-Q · filed 2014-08-08 | $2.58M 10-Q · filed 2014-08-08 | $3.62M derived: sum of 3 quarters · filed 2015-03-13 | $4.61M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2013-03-31 | $1.31M 10-Q · filed 2014-05-12 | $2.36M derived: sum of 2 quarters · filed 2015-03-13 | $3.35M derived: sum of 3 quarters · filed 2015-03-13 | $4.23M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $2.04M derived: sum of 2 quarters · filed 2015-03-13 | $2.92M derived: sum of 3 quarters · filed 2015-03-13 | $5.31M 10-K · filed 2015-03-13 | |||
| 2012-09-30 | $993.00K 10-Q · filed 2013-11-12 | $1.88M derived: sum of 2 quarters · filed 2013-11-12 | $4.26M 10-Q · filed 2013-11-12 | $5.29M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-06-30 | $882.00K 10-Q · filed 2013-08-09 | $3.27M 10-Q · filed 2013-08-09 | $4.30M derived: sum of 3 quarters · filed 2014-03-14 | $5.26M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-03-31 | $2.39M 10-Q · filed 2013-05-08 | $3.42M derived: sum of 2 quarters · filed 2014-03-14 | $4.37M derived: sum of 3 quarters · filed 2014-03-14 | $5.24M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $1.99M derived: sum of 2 quarters · filed 2014-03-14 | $2.85M derived: sum of 3 quarters · filed 2014-03-14 | $3.44M 10-K · filed 2014-03-14 | $20.39M 10-K · filed 2012-03-13 | ||
| 2011-09-30 | $954.00K 10-Q · filed 2012-11-08 | $1.82M derived: sum of 2 quarters · filed 2012-11-08 | $2.40M 10-Q · filed 2012-11-08 | $19.36M 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $869.00K 10-Q · filed 2012-08-09 | $1.45M 10-Q · filed 2012-08-09 | $18.40M 10-Q · filed 2011-08-09 | ||||
| 2010-12-31 | $585.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $1.13M derived: sum of 2 quarters · filed 2013-03-15 | $1.63M derived: sum of 3 quarters · filed 2013-03-15 | $2.12M 10-K · filed 2013-03-15 | |||
| 2010-09-30 | $545.00K 10-Q · filed 2011-11-08 | $1.05M derived: sum of 2 quarters · filed 2011-11-08 | $1.53M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $502.00K 10-Q · filed 2011-08-09 | $986.00K 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $1.81M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |